The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat PMID: 12591111 Eur J Pharmacol
Yardim A, Gur C, Comakli S, Ozdemir S, Kucukler S, et al
So can you drink while on steroids
The Society welcomes NICEs endorsement of lebrikizumab as an additional treatment option for eligible individuals with moderate to severe atopic eczema, emphasizing the importance of providing diverse treatment choices to match patients needs. Jorgen Damsbo, General Manager at Almirall, UK, remarked, The NICE recommendation for lebrikizumab reflects its proven effectiveness with 4-weekly maintenance dosing and a favorable safety profile, aligning with our commitment to improving patients lives by helping them achieve better health. Professor Tony Bewley, Consultant Dermatologist at Barts Health NHS Trust and Honorary Professor of Dermatology at QMUL, emphasized the significant psychosocial burden of atopic dermatitis, noting that lebrikizumabs approval marks a crucial advancement that is welcomed by both patients and clinicians

Neuropharmacology 51:789804 Brennan GP, Garcia-Curran MM, Patterson KP, Luo R, Baram TZ (2021) Multiple disruptions of glial-neuronal networks in epileptogenesis that follows prolonged febrile seizures